Oxford Pharmaceuticals, LLC
NDC labeler code: 69584
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- ParoxetinePaxil, Paxil CR, Brisdelle · 4 products
- Sotalol hydrochlorideSotalol Hydrochloride Af, Betapace Af, Betapace · 4 products
- BuspironeBucapsol · 4 products
- Imipramine3 products
- AmlodipineNorvasc, Sdamlo, Norliqva · 3 products
- Dipyridamole3 products
- SpironolactoneAldactone · 3 products
- GlipizideGlucotrol XL · 2 products
- HydrochlorothiazideInzirqo · 2 products
- PrimidoneMysoline · 2 products
- MethocarbamolRobaxin, Atmeksi, Tanlor · 2 products
- Trazodone hydrochlorideRaldesy Tm · 2 products
- CarisoprodolSoma · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 21, 2010 | ANDA076968 | Paroxetine PAROXETINE HYDROCHLORIDE | Oxford Pharms |
| April 7, 2010 | ANDA078414 | Amlodipine AMLODIPINE BESYLATE | Oxford Pharms |
| February 28, 2008 | ANDA040751 | Imipramine IMIPRAMINE HYDROCHLORIDE | Oxford Pharms |
| December 17, 2007 | ANDA078302 | Buspirone BUSPIRONE HYDROCHLORIDE | Oxford Pharms |
| August 29, 2006 | ANDA040750 | Spironolactone SPIRONOLACTONE | Oxford Pharms |
| April 21, 2006 | ANDA040542 | Dipyridamole DIPYRIDAMOLE | Oxford Pharms |
| February 24, 2005 | ANDA040586 | Primidone PRIMIDONE | Oxford Pharms |
| November 7, 2003 | ANDA075563 | Sotalol hydrochloride SOTALOL HYDROCHLORIDE | Oxford Pharms |
| January 29, 2003 | ANDA040489 | Methocarbamol METHOCARBAMOL | Oxford Pharms |
| May 9, 2002 | ANDA075388 | Buspirone BUSPIRONE HYDROCHLORIDE | Oxford Pharms |
| March 7, 1997 | ANDA040188 | Carisoprodol CARISOPRODOL | Oxford Pharms |
| November 28, 1994 | ANDA074378 | Glipizide GLIPIZIDE | Oxford Pharms |
| February 2, 1989 | ANDA072192 | Trazodone hydrochloride TRAZODONE HYDROCHLORIDE | Oxford Pharms |
| February 2, 1989 | ANDA072193 | Trazodone hydrochloride TRAZODONE HYDROCHLORIDE | Oxford Pharms |
| November 5, 1980 | ANDA087059 | Hydrochlorothiazide HYDROCHLOROTHIAZIDE | Oxford Pharms |
| November 5, 1980 | ANDA087068 | Hydrochlorothiazide HYDROCHLOROTHIAZIDE | Oxford Pharms |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2021
-
May 5, 2021 · Class II · Completed · D-0602-2021 · Buspirone
Presence of Foreign Tablets/Capsules
BusPIRone Hydrochloride Tablets, USP, 15 mg, 100-count bottle, Rx only, Manufactured By: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211, NDC 69584-093-10
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026